Clinical Trials Directory

Trials / Completed

CompletedNCT04993053

Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures

Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures in Patients Over 65 Years of Age

Status
Completed
Phase
Study type
Observational
Enrollment
61 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Intramedullary nailing is the standard treatment of trochanteric fractures. Mechanical failure such as cut-out and cut-through are associated with high rates of revision surgery, functional impairment and mortality. Augmentation of the implant have shown encouraging results in reducing the number of mechanical failures. The aim of the study was to evaluate the rate of mechanical failure of the cement augmented screws of TFNA nails. A descriptive, retrospective, multi-operator, single-centre study was performed at our level 1 trauma centre. Patients were included if they were \> 65 years of age, presented with a trochanteric fracture treated with an augmented TFNA nail. The primary outcome was fixation failure rate (cut-out or cut-through) at 3 and 6 postoperative months. Secondary endpoints were intraoperative data, clinical scores, and radiographic analysis.

Conditions

Timeline

Start date
2019-06-20
Primary completion
2020-06-03
Completion
2020-09-15
First posted
2021-08-06
Last updated
2021-08-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04993053. Inclusion in this directory is not an endorsement.

Use of Cemented TFNA Nail Augmentation in the Treatment of Trochanterian Rock Fractures (NCT04993053) · Clinical Trials Directory